Dr. Mohamed Mosaad Salama
My Social Links

Dr. Mohamed Mosaad Salama

Post-doctoral Fellow
Mansoura University, Egypt


Highest Degree
M.D. in Neurotoxicology from Mansoura University, Egypt

Share this Profile

Area of Interest:

Biomedical Sciences
100%
Neurodegenerative Disorders
62%
Regenerative Medicine
90%
Stem Cells
75%
Neurodegenaration
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Teixeira, S., S. Machado, F. Paes, B. Velasques and J.G. Silva et al., 2013. Time perception distortion in neuropsychiatric and neurological disorders. CNS Neurol. Disorders-Drug Targets, 12: 567-582.
    CrossRef  |  PubMed  |  
  2. Salama, M., T.F. Yuan, S. Machado, E. Murillo-Rodriguez and J.A. Vega et al., 2013. Co-enzyme Q10 to treat neurological disorders: Basic mechanisms, clinical outcomes and future research direction. CNS Neurol. Disorders-Drug Targets, 12: 641-664.
    CrossRef  |  PubMed  |  
  3. Salama, M., S.M. Farrag, S.A. Abulasrar, M.M. Amin and A. Abdel-Aziz et al., 2013. Up-regulation of TLR-4 in the brain after ischemic kidney-induced encephalopathy in the rat. CNS Neurol. Disorders-Drug Targets, 12: 583-586.
    CrossRef  |  PubMed  |  
  4. Salama, M., B. Helmy, M. El-Gamal, A. Reda and A. Ellaithy et al., 2013. Role of l-thyroxin in counteracting rotenone induced neurotoxicity in rats. Environ. Toxicol. Pharmacol., 35: 270-277.
    CrossRef  |  Direct Link  |  
  5. Abou-Donia, M.B., M. Salama and M. Islam, 2013. Autoantibodies against cytoskeletal neuronal proteins in sera of arsenic-exposed subjects correlate with neurological symptoms. Toxicol. Environ. Chem., 95: 823-836.
    CrossRef  |  Direct Link  |  
  6. Salama, M., S.A.E.A. Eldakroury, D. ElTantawy, A.A. Ghanem, H. Abd Elghaffar, M. Elhusseiny and S. Gad Elhak, 2012. Regenerative effects of umbilical cord matrix cells (UCMCs) in a rodent model of rotenone neurotoxicity. Environ. Toxicol. Pharmacol., 34: 338-344.
    CrossRef  |  Direct Link  |  
  7. Salama, M., A. Ellaithy, B. Helmy, M. El-Gamal and D. Tantawy et al., 2012. Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease. CNS Neurol. Disorders-Drug Targets, 11: 836-843.
    CrossRef  |  
  8. Salama, M., 2012. Huwe1: A possible role in PD. Med. Hypotheses, 79: 419-419.
    CrossRef  |  Direct Link  |  
  9. Arias-Carion, O. and M. Salama, 2012. Reward-seeking behavior and addiction: Cause or cog? Curr. Drug Abuse Rev., 5: 178-189.
    CrossRef  |  PubMed  |  
  10. Salama, M. and O. Arias-Carion, 2011. Natural toxins implicated in the development of Parkinson's disease. Ther. Adv. Neurol. Disorders, 4: 361-373.
    CrossRef  |  Direct Link  |  
  11. Salama, M. and O. Arias-Carion, 2011. Colchicine as a promising drug for Parkinson's disease. Med. Hypotheses, 76: 150-150.
    CrossRef  |  PubMed  |  Direct Link  |  
  12. Arias-Carion, O. and M. Salama, 2011. Reprogramming neurons by microRNAs into iPSCs to treat Parkinson's disease. Med. Hypotheses, 77: 312-313.
    CrossRef  |  PubMed  |  Direct Link  |  
  13. Gad Elhak, S., A.A.A. Ghanem, H. Abdelghaffar, S. Eldakroury and M. Salama, 2010. Parkinson's disease: Is it a toxic syndrome? Neurol. Res. Int. 10.1155/2010/103094.
    CrossRef  |  PubMed  |  Direct Link  |  
  14. Gad Elhak, S., A. Ghanem, H. Abdelghaffar, S. Eldakroury, D. ElTantawy, S. ElDosouky and M. Salama, 2010. The role of pramipexole in a severe Parkinson's disease model in mice. Ther. Adv. Neurol. Disorders, 3: 333-337.
    CrossRef  |  
  15. Salama, M., 2009. Lead and hypertension. High Blood Pressure Cardiovasc. Prev., 16: 83-85.
    CrossRef  |  Direct Link  |  
  16. Gad ElHak, S.A., A.M. El-Ghazali, M.M. Salama and A.Y. Aboelyazeed, 2009. Fatal suicide cases in Port Said city, Egypt. J. Forensic Legal Med., 16: 266-268.
    CrossRef  |  Direct Link  |